Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis-Reference-Cited by-同舟云学术

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis

Published:2023-04 Issue:4 Volume:41 Page:740-756.e10
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Zhou Wei,Liu Heng,Yuan Zhe,Zundell Joseph,Towers Martina,Lin Jianhuang,Lombardi Simona,Nie Hao,Murphy Brennah,Yang Tyler,Wang Chen,Liao Liping,Goldman Aaron R.,Kannan Toshitha,Kossenkov Andrew V.,Drapkin Ronny,Montaner Luis J.,Claiborne Daniel T.,Zhang Nan,Wu Shuai,Zhang Rugang^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference74 articles.

1. ARID1A mutations in cancer: another epigenetic tumor suppressor?;Wu;Cancer Discov.,2013

2. ARID1A mutations in endometriosis-associated ovarian carcinomas;Wiegand;N. Engl. J. Med.,2010

3. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma;Jones;Science,2010

4. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions;Guan;Neoplasia,2012

5. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers;Chan;Gynecol. Oncol.,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of pyroptosis mechanism and in-depth analysis of cardiomyocyte pyroptosis mediated by NF-κB pathway in heart failure;Biomedicine & Pharmacotherapy;2024-10

2. The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer;BJU International;2024-09-10

3. Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling;Genes & Diseases;2024-09

4. Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma;Biomedicines;2024-08-21

5. ELANE is a promising prognostic biomarker that mediates pyroptosis in gastric cancer;Heliyon;2024-07